Larson Financial Group’s AnaptysBio ANAB Stock Holding History

Larson Financial Group’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110K	Sell	1,624 -2	-0.1%	-$121	﹤0.01%	1136
2026 Q1	$90.2K	Buy	1,626 +2	+0.1%	+$108	﹤0.01%	1040
2025 Q4	$78.7K	Buy	1,624 +284	+21%	+$11.1K	﹤0.01%	1022
2025 Q3	$41K	Buy	1,340 +473	+55%	+$10.9K	﹤0.01%	1243
2025 Q2	$19.2K	Buy	867 +724	+506%	+$15.2K	﹤0.01%	1506
2025 Q1	$2.66K	Buy	+143	New	+$2.39K	﹤0.01%	2079

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Larson Financial Group's ANAB Position: Q2 2026 in Review

Larson Financial Group reduced its AnaptysBio (ANAB) stake by 0.12% in Q2 2026, selling an estimated $121 and leaving 1,624 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Larson Financial Group first reported a position in ANAB in Q1 2025 and has held it in 6 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Larson Financial Group held 1,624 shares of AnaptysBio worth $110K as of Q2 2026.
Larson Financial Group sold 2 AnaptysBio shares in Q2 2026, an estimated $121.
AnaptysBio made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1136 holding.
Larson Financial Group first reported a position in AnaptysBio in Q1 2025 and has held it in 6 quarters since.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.